Epicutaneous application of the anaesthetic cream Emla (lignocaine and prilocaine), to induce percutaneous anaesthesia in 38 patients scheduled for eyelid skin surgery is presented. The cream was applied 60 to 90 minutes before operation. In 36 out of the 38 patients (94.8%) no supplementary analgesia was required. The pain during the procedure was rated either as no pain in 29 patients (76.3%), slight pain in five patients (13%), moderate pain in two patients (5.2%), and severe pain in two patients (5.2%). Percutaneous anaesthesia induced by Emla cream is a useful and painless alternative method for analgesia in eyelid skin surgery. (BrJ7 Ophthalmol 1994; 78: 209-210) In the cases of dermatochalasis the procedure was performed at the same time in both left and right upper eyelids. However, in cases of xanthelasma situated in both the upper and the lower eyelid a simultaneous surgical procedure in both eyelids of the same eye was avoided because of the increased probability of the anaesthetic cream getting onto the eye. In other skin lesions there should be a limit of at least 2 mm between the lesion and the eyelid margin, thus affording enough area for taping the plastic wrap.
Percutaneous anaesthesia may be achieved by the infiltration of several local anaesthetics. The disadvantage of this procedure is that the subcutaneous injection of a local anaesthetic may produce pain by penetration of the needle and injection of the solution. Moreover, swelling of the skin, resulting after any infiltration influences the anatomical relations of the area and the definition of the surgical margin becomes more difficult.
Emla 5% cream (eutectic mixture of local anaesthetics; Astra Pharmaceuticals, Sweden) consists of 25 mg/ml (107 mmolllitre) lignocaine base and a 25 mg/ml (113 mmol/litre) prilocaine base with a thickener (Carbopol 934) To do this, before applying the cream, plastic wrap was taped first at the site of the eyelashes and a few drops of proxymetacaine hydrochloride 05% (Alcaine) were instilled into the conjuctival sac. After applying Emla cream, the patient was free to blink the eyelids as desired and was not obliged to keep the eyes closed.
In the cases of dermatochalasis the procedure was performed at the same time in both left and right upper eyelids. However, in cases of xanthelasma situated in both the upper and the lower eyelid a simultaneous surgical procedure in both eyelids of the same eye was avoided because of the increased probability of the anaesthetic cream getting onto the eye. In other skin lesions there should be a limit of at least 2 mm between the lesion and the eyelid margin, thus affording enough area for taping the plastic wrap.
The dose of Emla used in the study was 'a thick layer ofcream'. In a previous trial, a dose of 15 g Emla per 100 cm2 was found to be sufficient for the cutting of split skin grafts.7
None of the patients was premedicated with a sedative, and after a minimum of 1 hour, the occlusive dressing was removed and the cream wiped off with a dry swab. The eyelid skin was examined for a local reaction such as oedema, redness, or paleness, which was recorded by the surgeon. The area was then disinfected with 0 5% chlorhexidine gluconate in 70% alcohol. Before operation the patient was asked about any discomfort, particularly smarting pain or itching caused by the cream. The patients were asked to rate the pain they had experienced during the operation on a four point scale as none, slight, moderate, or severe.
Results
All surgical procedures were performed without the need of additional analgesia in 36 
